ArticleTherapeutic advances in medical oncology2024

First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis.

Wentao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.